NIMGenetics is a Spanish leading European company specializing in genetic diagnosis, using DNA microarrays, Next Generation Sequencing and FISH probes, all of them with medical applications in different areas (Gynecology, Paediatrics and Neuropaediatrics, Oncohematology, etc.) We consider our presence in foreign markets as a strategic cornerstone. This is the reason why we started our international expansion phase in the year 2016.
Our strategic goal is to provide medical specialists our diagnostic tools and our knowledge of the human genome in benefit of their patients.
In addition NIMGenetics is investing to reach markets that we understand can be the spearhead of our positioning and international development. By this way, we want that a greater number of physicians and patients can benefit from our diagnosis.
Nowadays, NIMGenetics is present in Brazil with a integral laboratory focused in patients and a team of geneticists highly qualified. Futhermore, we have collaborators in Mexico, Colombia, Chile, Peru, Paraguay, Uruguay, UK, Portugal and India.
NIMGenetics has development an investment plan for the next three years with this goals:
- Increase the inversion in our actual markets to consolidate the enterprise position
- Introduces our services in new markets